Denise Falardeau
Adult Health · Loma Linda, CANPI 1033512595
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $479 of the $568 with a category attached, or 84.3%. 13 manufacturers reported payments, led by AstraZeneca at 24.6% of the total. Reporting peaked in 2024 at $230 and has fallen 78.7% since, to $49 in 2025.
Across 19 payments — averaging $29.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$140
- AbbVie$92
- Pharmacyclics LLC, An Abbvie Company$89
- Abiomed$49
- Amgen$28
- Endotronix, Inc.$26
- plus $145 from 7 others
What the payments were for
- Food & beverage$47984%
- Education$8916%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $140 |
| AbbVie | 4 | $92 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $89 |
| Abiomed | 3 | $49 |
| Amgen | 1 | $28 |
| Endotronix, Inc. | 1 | $26 |
| Pfizer | 1 | $25 |
| Bristol Myers Squibb | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Edwards Lifesciences | 1 | $19 |
| Novo Nordisk | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$125
How this compares
$568 in reported general payments places this provider in the 55th percentile of 785 adult health providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other adult health in Loma Linda
- Karolina FaysmanLos Angeles$1.1M
- Linda BuckLos Angeles$170K
- Naomi PesynaAnaheim$141K
- Stacy GrissenEncinitas$82K
- Kimberly PodsadaSan Diego$78K
- Brenda PatrickSan Leandro$68K
- Brittany PolizziEncinitas$35K
- Nancy NicolosiLaguna Woods$31K
- Michele WestendorfNewport Beach$30K
- Lisa HinemanLos Angeles$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.